Global Blood Therapeutics, Inc.
GBTDelisted Oct 5, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001629137
Global Blood Therapeutics, Inc. was delisted on Oct 5, 2022; its insiders filed their last Form 4 on Oct 6, 2022; 247 institutions reported holding it in 13F filings for Q3 2022, worth $4.67B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Global Blood Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 214 | 1 | 192 | −21 |
| Shares | 66.4M | 4.60K | 65.1M | −1.23M (−1.9%) |
| Value | $2.70B | $187.0K | $2.28B | −$420.8M (−15.6%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Global Blood Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Natixis | 277,980 | $9.73M | 0.04% |
| Caption Management, LLC | 205,000 | $7.18M | 0.64% |
| Candriam Luxembourg S.C.A. | 196,330 | $6.88M | 0.05% |
| Duality Advisers, LP | 51,759 | $1.81M | 0.16% |
| Renaissance Technologies LLC | 50,680 | $1.77M | 0.00% |
| Manufacturers Life Insurance Company, The | 33,905 | $1.19M | 0.00% |
| Parallax Volatility Advisers, L.P. | 28,800 | $1.01M | 0.01% |
| AlphaCrest Capital Management LLC | 25,008 | $876.0K | 0.04% |
| MetLife Investment Management | 21,706 | $760.1K | 0.01% |
| Qube Research & Technologies Ltd | 20,438 | $716.0K | 0.01% |
| Schonfeld Strategic Advisors LLC | 19,500 | $683.0K | 0.01% |
| Virtu Financial LLC | 15,177 | $531.0K | 0.05% |
| Aigen Investment Management, LP | 11,432 | $400.0K | 0.07% |
| Fox Run Management, L.L.C. | 6,813 | $239.0K | 0.22% |
| Gsa Capital Partners LLP | 6,572 | $230.0K | 0.03% |
| Jefferies Group LLC | 5,494 | $192.4K | 0.00% |
| Ameritas Investment Partners, Inc. | 4,693 | $164.0K | 0.01% |
| Amundi | 4,172 | $146.0K | 0.00% |
| Healthcare of Ontario Pension Plan Trust Fund | 1,067 | $37.0K | 0.00% |
| Advisory Services Network, LLC | 36 | $1.00K | 0.00% |
Sold out (41)
Institutions that held Global Blood Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (1)
Institutions that held Global Blood Therapeutics, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 4,600 | $187.0K |